Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma
Cureus · 29.05.2026
DOI: 10.7759/cureus.109868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 29.05.2026. Verfasst von Ava Zamani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Wayne State University, Detroit, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Wayne State University, Detroit, USA.
- Department of Urology, Oakland University William Beaumont School of Medicine, Auburn Hills, USA.
- Department of Oncology, Karmanos Cancer Institute, Detroit, USA.
Zitieren
APA
Zamani, A., Cohn, H., Moser, A. M., Michael, Z., Krinock, M. J., Fung, G., Shao, Y. F., & Ginsburg, K. B. (2026). Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma. Cureus. https://doi.org/10.7759/cureus.109868
Vancouver
Zamani A, Cohn H, Moser AM, Michael Z, Krinock MJ, Fung G, et al. Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma. Cureus. 2026. doi:10.7759/cureus.109868
BibTeX
@article{Zamani2026,
author = {Zamani, Ava and Cohn, Hunter and Moser, Ana M and Michael, Zoe and Krinock, Matthew J and Fung, Gloria and Shao, Yusra F and Ginsburg, Kevin B},
title = {Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109868}
}
EUVIMED